THE Royal Navy and BAE have downplayed a national newspaper claim that Barrow’s first Astute class submarine hit a serious problem on its sea trials.
More: continued here
THE Royal Navy and BAE have downplayed a national newspaper claim that Barrow’s first Astute class submarine hit a serious problem on its sea trials.
More: continued here
Alliance Pharma said its investors would receive 62.5p per share under the deal DBAY believes …